Cellular perspectives on the glutamate-monoamine interactions in limbic lobe structures and their relevance for some psychiatric disorders

Neuroscience

• Glutamic Acid 100%
• Dementia Praecox 66%
• Limbic Lobe 66%
• Parkinson's Disease 33%
• Physical Dependence 33%
• Monoamine 33%
• Dopaminergic 33%
• Receptor Antagonist 33%
• Serotonergic 33%
• Antipsychotic 33%
• Chlorpromazine 33%
• Depression 33%
• Dopamine Receptor D2 33%

Pharmacology, Toxicology and Pharmaceutical Science

• Glutamic Acid 100%
• Pathophysiology 66%
• Schizophrenia 66%
• Drug 33%
• Monoamine 33%
• Dopamine Receptor Stimulating Agent 33%
• Chlorpromazine 33%
• Parkinson Disease 33%
• Base 33%
• Depression 33%
• Drug Dependence 33%
• Dopamine 2 Receptor Blocking Agent 33%

Medicine and Dentistry

• Pathophysiology 66%
• Combination Therapy 33%
• Parkinson's Disease 33%
• Drug 33%
• Neurotransmitter 33%
• Chemotherapeutic Agent 33%
• Monoamine 33%
• Dopamine Agonist 33%
• Depression 33%
• Dopamine 2 Receptor Blocking Agent 33%
• Chlorpromazine 33%
• Substance Use Disorder 33%
• Base 33%